{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:03:07Z","timestamp":1773932587989,"version":"3.50.1"},"reference-count":11,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T00:00:00Z","timestamp":1615161600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["acrjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Arthritis & Rheumatology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1002\/art.41638","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T22:18:36Z","timestamp":1609971516000},"page":"721-724","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Reassessing the Cardiovascular Safety of Febuxostat: Implications of the Febuxostat versus Allopurinol Streamlined Trial"],"prefix":"10.1002","volume":"73","author":[{"given":"Hyon K.","family":"Choi","sequence":"first","affiliation":[{"name":"Massachusetts General Hospital  Boston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9515-1711","authenticated-orcid":false,"given":"Tuhina","family":"Neogi","sequence":"additional","affiliation":[{"name":"Boston University School of Medicine  Boston Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0138-2912","authenticated-orcid":false,"given":"Lisa K.","family":"Stamp","sequence":"additional","affiliation":[{"name":"University of Otago  Christchurch New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5368-7473","authenticated-orcid":false,"given":"Robert","family":"Terkeltaub","sequence":"additional","affiliation":[{"name":"VA San Diego Healthcare System and University of California San Diego"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4632-4476","authenticated-orcid":false,"given":"Nicola","family":"Dalbeth","sequence":"additional","affiliation":[{"name":"University of Auckland  Auckland New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2021,3,8]]},"reference":[{"key":"e_1_2_3_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1710895"},{"key":"e_1_2_3_3_1","unstructured":"US Food and Drug Administration.FDA adds boxed warning for increased risk of death with gout medicine Uloric (febuxostat): FDA drug safety communication. February2019. URL:https:\/\/www.fda.gov\/drugs\/\u200bdrug\u2010safet\u200by\u2010and\u2010avail\u200babili\u200bty\/fda\u2010adds\u2010boxed\u200b\u2010warni\u200bng\u2010incre\u200based\u2010risk\u2010death\u200b\u2010gout\u2010medic\u200bine\u2010ulori\u200bc\u2010febux\u200bostat."},{"key":"e_1_2_3_4_1","doi-asserted-by":"crossref","unstructured":"KimSC NeogiT KimE LiiJ DesaiRJ.Trends in utilization of urate\u2010lowering therapies following the US Food and Drug Administration\u2019s boxed warning on febuxostat. Arthritis Rheumatol2021;73:542\u20133.","DOI":"10.1002\/art.41550"},{"key":"e_1_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32234-0"},{"key":"e_1_2_3_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.40583"},{"key":"e_1_2_3_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1912388"},{"key":"e_1_2_3_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021372"},{"key":"e_1_2_3_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.39723"},{"key":"e_1_2_3_10_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.033992"},{"key":"e_1_2_3_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1377"},{"key":"e_1_2_3_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez189"}],"container-title":["Arthritis & Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.41638","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/art.41638","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.41638","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T12:58:06Z","timestamp":1759928286000},"score":1,"resource":{"primary":{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/10.1002\/art.41638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,8]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["10.1002\/art.41638"],"URL":"https:\/\/doi.org\/10.1002\/art.41638","archive":["Portico"],"relation":{},"ISSN":["2326-5191","2326-5205"],"issn-type":[{"value":"2326-5191","type":"print"},{"value":"2326-5205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,8]]},"assertion":[{"value":"2020-11-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}